Malignant insulinoma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer

• Publication date

  2005-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.21179PMID 15937909PMCID PMC4136659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmune reactions in a patient with malignant insulinoma treated by multiple low dose streptozotocin.

  2009cited by this paper
• Metastatic Insulinoma: Case Report and Review of the Literature

  2004cited by this paper
• Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors.

  2003cited by this paper
• A Large Malignant Insulinoma: Case Report with Endosonographic, Immunohistochemical and Ultrastructural Features

  2003cited by this paper
• Radio‐frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma

  2002cited by this paper
• Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach.

  2002cited by this paper
• Difficult insulinoma.

  2001cited by this paper
• Islet cell tumors of the pancreas: the medical oncologist's perspective.

  2001cited by this paper
• Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

  2001cited by this paper
• Malignant insulinoma with hepatoid differentiation: A unique case with alpha-fetoprotein production

  2001cited by this paper
• Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours

  2000cited by this paper
• Intra-Arterial Liver Chemotherapy and Hormone Therapy in Malignant Insulinoma: Case Report and Review of the Literature

  2000cited by this paper
• Forty-eight-hour fast: the diagnostic test for insulinoma.

  2000cited by this paper
• Natural history of a proinsulin-secreting insulinoma: from symptomatic hypoglycemia to clinical diabetes.

  2000cited by this paper
• Preoperative localization of insulinomas is not necessary.

  1999cited by this paper
• Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms.

  1999cited by this paper
• Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.

  1999cited by this paper
• Malignant insulinoma presenting a non-functioning metastatic liver tumor 14 years after resection of the primary tumor

  1998cited by this paper
• Diazoxide treatment for insulinoma: a national UK survey.

  1997cited by this paper
• Acinar-islet cell carcinoma presenting as insulinoma

  1997cited by this paper
• Plasma proinsulin-like component in insulinoma: a 25-year experience.

  1995cited by this paper
• Localization of Insulinomas to Regions of the Pancreas by Intra-arterial Stimulation with Calcium

  1995cited by this paper
• Malignant insulinoma: Permanent hepatic artery embolization of liver metastases—Preliminary results

  1995cited by this paper
• Malignant insulinoma causing liver metastasis 8 years after the initial surgery: Report of a case

  1995cited by this paper
• Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization

  1992cited by this paper
• Prospective study of aggressive resection of metastatic pancreatic endocrine tumors.

  1992cited by this paper
• Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes

  1992cited by this paper
• Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.

  1991influential reference
• Successful treatment of hypoglycemia using glucagon in a patient with an extrapancreatic tumor.

  1990cited by this paper
• Immunocytochemical staining for human chorionic gonadotropin subunits does not predict malignancy in insulinomas.

  1990cited by this paper
• Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors

  1989cited by this paper
• Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut

  1989cited by this paper
• Aggressive Insulinoma with Bone Metastases

  1989cited by this paper
• Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.

  1988cited by this paper
• Remission of Symptoms of Chemotherapy-Refractory Metastatic Insulinoma using Octreotide

  1988cited by this paper
• Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery.

  1984cited by this paper
• Metastatic insulinoma with long survival and glucagonoma syndrome.

  1984cited by this paper
• Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.

  1980cited by this paper
• Islet cell tumors: current concepts and management.

  1973cited by this paper

• A Rare Case of Asymptomatic Insulinoma with Mesocolonic Lymph Node Metastases and Long-Term Stability.

  2026cites this paper
• Peptide receptor radionuclide therapy in malignant insulinoma.

  2025cites this paper
• History of an Insidious Case of Metastatic Insulinoma

  2025cites this paper
• Recurrence of malignant insulinoma in the context of multiple endocrine neoplasia type 1: a case report

  2025cites this paper
• INSULINOMA: CONTEMPORARY STRATEGIES FOR DIAGNOSIS, CLINICAL PRESENTATION, AND MULTIMODAL TREATMENT OF PANCREATIC NEUROENDOCRINE INSULIN-SECRETING TUMORS

  2025cites this paper
• Clinical Relevance of ATRX/DAXX Gene Mutations and ALT in Functioning Pancreatic Neuroendocrine Tumors

  2025cites this paper
• 28-Year-Old Woman With Undifferentiated Spells.

  2025cites this paper
• Prognosis of small pancreatic neuroendocrine neoplasms: Functionality matters.

  2025cites this paper
• Pancreatic Insulinoma Masquerading as Neurological Disease: Diagnosis and Treatment of a Rare Tumor

  2024cites this paper
• Современные взгляды на лечение инсулиномы

  2024cites this paper
• Metastatic insulinoma—outcomes in the current era

  2024influential citation
• Sweet Saboteur: Insulinoma Presenting As Recurrent Hypoglycemic Seizures

  2024cites this paper
• Short fasting test as a reliable and effective tool to diagnose insulinoma

  2024cites this paper
• Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia

  2023cites this paper
• Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT)

  2023cites this paper
• Insulinoma as a cause of seizure-like activity and spontaneous hypoglycaemia

  2023cites this paper
• Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care

  2023cites this paper
• Clinical presentation and diagnostic approach to hypoglycemia in adults without diabetes mellitus.

  2022cites this paper
• Metastatic insulinoma presenting after bariatric surgery in a patient diagnosed with MEN1

  2022cites this paper
• Could the burden of pancreatic cancer originate in childhood?

  2021cites this paper
• Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases

  2021cites this paper
• Challenge of coexisting type 2 diabetes mellitus and insulinoma: a case report

  2021cites this paper
• Toxic and Metabolic Diseases

  2021cites this paper
• Multiple Endocrine Neoplasia Type 1 with Concomitant Existence of Malignant Insulinoma: A Rare Finding

  2021influential citation
• Clinical characteristics and incidences of benign and malignant insulinoma using a national inpatient database in Japan.

  2021cites this paper
• Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management

  2021cites this paper
• Pancreatic neuroendocrine carcinoma in a pregnant woman: A case report and review of the literature

  2021cites this paper
• Feasible laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors.

  2021cites this paper
• Case Report and Literature Review of Insulinoma in the Geriatric Population: An 86-Year-Old Female with Syncope of Unknown Origin

  2020cites this paper
• Comparison of benign and malignant insulinoma.

  2020cites this paper
• Vasoactive intestinal peptide-oma causing refractory diarrhea in a young woman

  2020influential citation
• Malignant Insulinoma with Multiple Liver Metastases and Hypercalcitoninemia in a Patient with Type 2 Diabetes Mellitus Presenting as Recurrent Episodes of Diaphoresis due to Severe Hypoglycemia

  2020cites this paper
• [Complexity of the management of an insulinoma in a nonagenarian patient].

  2020cites this paper
• Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas

  2020cites this paper
• Cancer of the Endocrine System

  2020cites this paper
• Malignant Insulinoma: A Rare Form of Neuroendocrine Tumor

  2020influential citation
• Advances in the Diagnosis and Management of Insulinoma

  2020cites this paper
• Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.

  2020cites this paper
• Keeping a Low Profile: Insulinoma.

  2019cites this paper
• Gamma emitters in pancreatic endocrine tumors imaging in the PET era: is there a clinical space for 99mTc-peptides?

  2019cites this paper
• Alcohol-free EUS-guided chemoablation of multiple pancreatic insulinomas

  2019cites this paper
• Sudden 'cure' of type two diabetes due to pancreatic insulinoma: A case report.

  2019cites this paper
• Pancreatic Insulinoma: Case Report of Rare Tumor

  2019cites this paper
• Treatment of Gastroenteropancreatic Neuroendocrine Tumors.

  2019cites this paper
• Hypoglycemia After Gastric Bypass Successfully Treated With Calcium Channel Blockers: Two Case Reports

  2019cites this paper
• Insulinoma

  2019cites this paper
• Malignant insulinoma chemotherapy resistant, pancreatic neuroendocrine tumor of uncertain prognosis

  2018cites this paper
• A case of malignant insulinoma responsive to somatostatin analogs treatment

  2018cites this paper
• Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors.

  2018cites this paper
• Screening key candidate genes and pathways involved in insulinoma by microarray analysis

  2018cites this paper
• Imaging features of malignant abdominal neuroendocrine tumors with rare presentation.

  2018cites this paper
• Clinical spectrum of pancreatic beta cell tumors

  2018cites this paper
• Identifying therapeutic implications of cancer stem cells in human and canine insulinoma

  2018cites this paper
• Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma

  2018cites this paper
• Clinical Management of Malignant Insulinoma: a single Institution’s experience over three decades

  2018influential citation
• Embolización de metástasis hepáticas en insulinoma maligno: de la hipoglicemia a la hiperglicemia

  2017cites this paper
• Diagnosis and Treatment of Insulinoma: an up-to-date Overview

  2017cites this paper
• Characteristics of glucose metabolism indexes and continuous glucose monitoring system (CGMS) in patients with insulinoma

  2017cites this paper
• Glycemic control in patients with insulinoma

  2017cites this paper
• 12 Pancreatic Beta Cell Tumors

  2017cites this paper
• A severe but reversible reduction in insulin sensitivity is observed in patients with insulinoma.

  2017cites this paper
• A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series

  2017cites this paper
• Effect of hormone secretory syndromes on neuroendocrine tumor prognosis.

  2017cites this paper
• Chemoembolization with Epirubicin in the Treatment of Malignant Insulinoma

  2017cites this paper
• Radionuclide Imaging of Pancreatic Neuroendocrine Tumours

  2017cites this paper
• Pancreatic Neuroendocrine Tumors

  2016cites this paper
• The treatment of hyperinsulinemic hypoglycaemia in adults: an update

  2016cites this paper
• Liver Metastases 10 Years after Resection of a “Benign” Insulinoma

  2016cites this paper
• Upregulation of INS-IGF2 read-through expression and identification of a novel INS-IGF2 splice variant in insulinomas.

  2016cites this paper
• Clinical characteristics and management of insulin-producing neuroendocrine carcinomas.

  2016cites this paper
• Pancreatic surgery for tumors in children and adolescents

  2016cites this paper
• Giant Malignant Insulinoma

  2016cites this paper
• Metastatic Insulinoma in a 16-Year-Old Adolescent Male With Men-1: A Case Report and Review of the Literature

  2016cites this paper
• Non-Diabetic Hypoglycemia

  2016cites this paper
• A Case of Metastatic Insulinoma: Management and Review of Literature

  2016cites this paper
• Chapter 150 – Neuroendocrine Tumor Syndromes

  2016cites this paper
• Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study

  2015cites this paper
• Management of Islet Cell Tumours: A Single Hospital Experience.

  2015cites this paper
• Advances in the management of unresectable or metastatic pancreatic neuroendocrine tumors: chemotherapy, targeted therapy, hormonal treatment, and future directions.

  2015cites this paper
• Management of Islet Cell Tumours: A Single Hospital Experience.

  2015cites this paper
• 68Ga DOTANOC PET/CT detects primary malignant insulinoma.

  2015cites this paper
• Different Raman spectral patterns of primary rat pancreatic β cells and insulinoma cells.

  2015cites this paper
• Insulinoma with focal hepatic lesions: malignant insulinoma?

  2015cites this paper
• Pancreatic insulinomas: Laparoscopic management.

  2015cites this paper
• Long‐Term Outcome after Clinical Management of Endocrine Tumors of the Pancreas

  2015cites this paper
• Insulinoma in the elderly : a report of three cases and review literature

  2014cites this paper
• Sporadic insulinoma in a 10-year-old boy: a case report and literature review.

  2014cites this paper
• Relevant infrastructural alterations in a pancreatic neuroendocrine tumor: an insulinoma case.

  2014cites this paper
• [Malignant insulinoma: recommendations for workup and treatment].

  2014cites this paper
• Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patients.

  2014cites this paper
• Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment

  2013cites this paper
• A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections.

  2013cites this paper
• Nonislet Cell Tumor Hypoglycemia

  2013cites this paper
• Malignant insulinoma: recommendations for characterisation and treatment.

  2013cites this paper
• Management of malignant insulinoma

  2013cites this paper
• Giant Insulinoma: A Report of 3 Cases and Review of the Literature

  2013cites this paper
• Diagnosis and management of insulinoma.

  2013cites this paper
• Practical guide to supportive care of patients with functional neuroendocrine tumors.

  2013cites this paper
• Type 2 diabetes mellitus in a patient with malignant insulinoma manifesting following surgery

  2012cites this paper
• Spontaneous regression of pancreatic cancer: real or a misdiagnosis?

  2012cites this paper